Li Y, Sang T, Lv N, Liu J, Gu Y, Han X
Ann Med. 2024; 57(1):2445200.
PMID: 39717998
PMC: 11703110.
DOI: 10.1080/07853890.2024.2445200.
Hirashiki A, Shimizu A, Kamihara T, Kokubo M, Hashimoto K, Ueda I
J Cardiovasc Dev Dis. 2024; 11(6).
PMID: 38921665
PMC: 11203550.
DOI: 10.3390/jcdd11060165.
Sosa F, Shaban M, Lopez J, Duarte G, Jain S, Khizar A
Clin Med Insights Cardiol. 2024; 18:11795468241239542.
PMID: 38529322
PMC: 10962038.
DOI: 10.1177/11795468241239542.
Kim S, Hwang B, Lee K, Kim C, Choo E, Lim S
J Clin Med. 2022; 11(19).
PMID: 36233397
PMC: 9573253.
DOI: 10.3390/jcm11195531.
Statescu C, Anghel L, Tudurachi B, Leonte A, Benchea L, Sascau R
Int J Mol Sci. 2022; 23(16).
PMID: 36012430
PMC: 9409468.
DOI: 10.3390/ijms23169168.
Association of Hyperuricemia with 10-Year Atherosclerotic Cardiovascular Disease Risk among Chinese Adults and Elders.
Chen F, Yuan L, Xu T, Liu J, Han S
Int J Environ Res Public Health. 2022; 19(11).
PMID: 35682297
PMC: 9180408.
DOI: 10.3390/ijerph19116713.
The Role of Uric Acid in Acute and Chronic Coronary Syndromes.
Maloberti A, Biolcati M, Ruzzenenti G, Giani V, Leidi F, Monticelli M
J Clin Med. 2021; 10(20).
PMID: 34682873
PMC: 8540994.
DOI: 10.3390/jcm10204750.
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.
Maloberti A, Giannattasio C, Bombelli M, Desideri G, Cicero A, Muiesan M
High Blood Press Cardiovasc Prev. 2020; 27(2):121-128.
PMID: 32157643
DOI: 10.1007/s40292-020-00368-z.
Oolong tea consumption and its interactions with a novel composite index on esophageal squamous cell carcinoma.
Liu S, Lin Z, Huang L, Chen H, Liu Y, He F
BMC Complement Altern Med. 2019; 19(1):358.
PMID: 31822288
PMC: 6902529.
DOI: 10.1186/s12906-019-2770-7.
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study.
Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyorala K
Diabetologia. 2005; 47(12):2118-28.
PMID: 15662552
DOI: 10.1007/s00125-004-1574-5.
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.
Hayden M, Tyagi S
Nutr Metab (Lond). 2004; 1(1):10.
PMID: 15507132
PMC: 529248.
DOI: 10.1186/1743-7075-1-10.
Clinical research methodology in ophthalmology.
Trans Am Ophthalmol Soc. 1980; 78:896-946.
PMID: 7257074
PMC: 1312162.
Incidence of coronary heart disease in a population insured for medical care (HIP): myocardial infarction, angina pectoris, and possible myocardial infarction.
Shapiro S, WEINBLATT E, Frank C, Sager R
Am J Public Health Nations Health. 1969; 59 Suppl 6:1-101.
PMID: 5814578
PMC: 1226328.
DOI: 10.2105/ajph.59.suppl_6.1.
A study of the primary prevention of coronary heart disease.
Keller M, Anthony J, GRESHAM G
Am J Public Health Nations Health. 1970; 60(8):1466-76.
PMID: 5465460
PMC: 1349134.
DOI: 10.2105/ajph.60.8.1466.
Effects of hyperlipoproteinemias and their treatment on the peripheral circulation.
Zelis R, Mason D, Braunwald E, Levy R
J Clin Invest. 1970; 49(5):1007-15.
PMID: 5441536
PMC: 535752.
DOI: 10.1172/JCI106300.
Does coffee influence the lipid metabolism?.
Heyden S
Z Ernahrungswiss. 1969; 9(4):388-96.
PMID: 5394270
DOI: 10.1007/BF02021519.
Developmental patterns in hypertensive cardiovascular disease: fact or fiction?.
Thomas C
Bull N Y Acad Med. 1969; 45(9):831-50.
PMID: 5257766
PMC: 1750531.
Acute myocardial infarction in a 21-year-old male with normal selective coronary arteriogram.
Ledwich J
Can Med Assoc J. 1971; 105(8):843-4.
PMID: 5162409
PMC: 1931211.
Lung function as a risk factor for coronary heart disease.
Keys A, ARAVANIS C, Blackburn H, DJORDJEVIC B, Dontas A, Fidanza F
Am J Public Health. 1972; 62(11):1506-11.
PMID: 5085517
PMC: 1530465.
DOI: 10.2105/ajph.62.11.1506.
The hyperlipoproteinemias. A simplified classification and approach to therapy.
Zelis R, Mason D, SPANN Jr J
Calif Med. 1970; 112(5):32-7.
PMID: 4924875
PMC: 1501269.
